Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report

A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days)....

Full description

Saved in:
Bibliographic Details
Published inInfection control and hospital epidemiology Vol. 33; no. 11; p. 1162
Main Authors Kamboj, Mini, Son, Crystal, Cantu, Sherry, Chemaly, Roy F, Dickman, Jeanne, Dubberke, Erik, Engles, Lisa, Lafferty, Theresa, Liddell, Gale, Lesperance, Mary Ellen, Mangino, Julie E, Martin, Stacy, Mayfield, Jennie, Mehta, Sapna A, O'Rourke, Susan, Perego, Cheryl S, Taplitz, Randy, Eagan, Janet, Sepkowitz, Kent A
Format Journal Article
LanguageEnglish
Published United States 01.11.2012
Subjects
Cancer Care Facilities
Clostridium difficile - isolation & purification
Clostridium Infections - epidemiology
Cross Infection - epidemiology
Cross Infection - etiology
Cross Infection - microbiology
Health Care Surveys
Hematopoietic Stem Cell Transplantation
Humans
Neoplasms - drug therapy
United States - epidemiology
United States
Online AccessGet more information

Cover

More Information
Summary:A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.
ISSN:1559-6834
DOI:10.1086/668023